Skip to content

Public FDA record

Z-1375-2024: Insufflation unit, UHI-4.

Recall record Z-1375-2024 for Olympus Corporation of the Americas. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1375-2024
Company in FDA record
Olympus Corporation of the Americas
FDA classification date
Mar 25, 2024
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Olympus has become aware of an increased trend of both repairs and customer complaints reporting "UHI-4 stopping air supply due to the front panel LED turning off".

Source facts

Action
On February 16, 2024, the firm notified customers of the issue via URGENT MEDICAL DEVICE CORRECTIVE ACTION letters. Customers were informed of a new action regarding the UHI-4 front LED control panel. These units should have been quarantined from a previous October 25, 2023 notification related to an overpressure issue. Olympus will replace the CR board for UHI-4 older than 4.5 years. This repair of the CR board will not correct or address the overpressure issue which was the reason for the quarantine noted in our October 25, 2023, communication regarding the overpressure situation. In connection with the overpressure issue, Olympus has identified software mitigations that will aid in the prevention of over pressurization situations. Olympus will be communicating with you at the end of summer 2024 regarding this software update for the UHI-4 device. If you decided to continue using the UHI-4, Olympus recommends a compatible insufflator be readily accessible as a backup during procedures. Action steps to be taken by the customer 1. Olympus will contact you based on device age and parts availability to schedule a repair to replace the CR board. Olympus will also be prioritizing this action for customers who have to continue using the UHI-4 during the quarantine action. To ensure continuity of care, Olympus will make every effort to provide a loaner while the unit is sent to the Olympus Service Center. 2. Please acknowledge receipt of this letter and, if applicable, indicate which serial numbers are still in use by your facility. 3. If you have further distributed this product, forward this letter to those facilities. Please contact your local Sales Representative for support regarding alternatives to the UHI-4 should you no longer wish to keep your UHI-4. Adverse events experienced with the use of this product may also be reported to the FDA s MedWatch Adverse Event Reporting program either online, by regular mail, or by fax. If you have questions about this recall, p
Initiated
2023-09-25
Root cause
Process control
Distribution
Domestic: Nationwide Distribution.
Recall number
Z-1375-2024
Recall status
Open, Classified
CDRH record ID
206261
FDA classified
2024-03-25
Recall event number
94080

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗